A Phase II Study of M7824 in Subjects With Recurrent Respiratory Papillomatosis
Phase of Trial: Phase II
Latest Information Update: 02 Jan 2019
At a glance
- Drugs MSB 0011359C (Primary)
- Indications Recurrent respiratory papillomatosis
- Focus Therapeutic Use
- 19 Dec 2018 Planned initiation date (estimated date of first participant enrollment) changed from 3 Dec 2018 to 25 Dec 2018.
- 27 Nov 2018 Planned initiation date (Estimated date of first participant enrollement ) changed from 26 Nov 2018 to 3 Dec 2018.
- 20 Nov 2018 Planned initiation date (Estimated date of first participant enrollement ) changed from 1 Nov 2018 to 26 Nov 2018.